CClinicalTrials.gg
CompletedNCT00593216Updated Jun 23, 2011

Diagnosis Of Vertigo With New Imaging

An observational study in Vertigo, sponsored by Boston University. Completed. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-06-23.

Sponsored by Boston University · Observational

Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
4
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to determine the potential usefulness of new functional MRI in diagnostic assessment of patients presenting with vertigo.

Read the detailed description

The incidence of vertigo has been reported to be as high as 1.5% in the general population and some reports suggest that more than 5% of adults experience some kind of vertigo each year. In 80% of affected individuals, this symptom resulted in a medical consultation, interruption of daily activities, or sick leave. Therefore, vertigo can have a significant impact on health and well being. Unfortunately, there is not yet any satisfactory objective method for diagnosis of vertigo. At present, the diagnosis usually depends on medical history, vestibular function tests, Dix-Hallpike positioning tests done in the office, and, to some extent imaging studies doen to look for such abnormalities such as acoustic tumor, brain tumor, and evidence of multiple sclerosis. A number of recent studies support the possibility of using functional MRI (fMRI), particularly a new diffusion tensor fiber tracking (DTT) technique, as a new tool for diagnosis of disorders that can cause vertigo. In this study, our hypothesis is that there is an alteration in the activity in neural pathways of patients with vertigo that can be detected by fMRI. To test this assumption, our objective in this study is to determine whether there is a difference between the fMRI images obtained in normal subjects versus those in patients with vertigo.

02

Conditions studied

  • Vertigo

Browse trials for

Keywords

  • functional magnetic Resonance Imaging
  • vertigo
  • vestibular
03

In context

Vertigo

248 studies on the registry are indexed under Vertigo; 39 are open to participants now.

This study's enrollment of 4 is below the median of 151 across 50 observational studies indexed under Vertigo.

Browse Vertigo studies →

Lead sponsor

Boston University is the lead sponsor of 266 studies on the registry; 37 are open to participants now.

Of its 30 completed or terminated interventional studies of FDA-regulated products, 24 (80%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

primary care clinic

Inclusion criteria

  • Healthy volunteer or patient with symptom of vertigo

Exclusion criteria

Exclusion Criteria:

  • Evidence of mental impairment
  • Any type of bioimplant or any type of ferromagnetic bioimplant
  • Pregnant females
  • Exhibit noticeable anxiety and/or claustrophobia
  • History of serious disease in central nervous and cerebrovascular systems.
05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
4 participants (actual)

Groups and cohorts

  • Healthy

    Healthy volunteers devoid of any ear problems

    Device: Functional MRI imaging

  • Vertigo

    Patients with the symptoms of vertigo

    Device: Functional MRI imaging

Interventions

  • DeviceFunctional MRI imaging

    The functional MRI imaging of whole brain will be obtained before, during and after the vestibular response which is induced by the designated caloric stimulation. Post-imaging analysis will reveal which region or neural pathways in the central nervous system may attributed to the development of vertigo.

    Also known as: Magnetic Resonance Imaging

06

What researchers measure

Primary outcomes

  1. Activation of target sites on the functional MRI images during the vestibular response

    Time frame: Not specific

Secondary outcomes

  1. Differences in the fiber tracking of central nervous system specifically involved in the vestibular response

    Time frame: Not specific

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 23, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00593216
Lead sponsor
Boston University
First posted
Jan 14, 2008
Start date
Jul 2007
Primary completion
Dec 2008
Completion
Dec 2008
Last update
Jun 23, 2011

Study contacts

Kenneth Grundfast, M.D.
principal investigator · Department of Otolaryngology- Head and Neck surgery of Boston University Medical Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion